Vadivarhe Speciality Chemicals Reports Audited Financial Results for FY 2026; Appoints Internal Auditors
Vadivarhe Speciality Chemicals Limited announced the results of its Board of Directors meeting held on May 28, 2026. The company approved the audited financial statements and results for the half year and the full Financial Year ended March 31, 2026. Furthermore, the board approved the appointment of M/s. Yatin and Associates, Chartered Accountants, as the Internal Auditors for the financial year 2026-27.The company released its financial performance data, alongside the statutory audit report from S. R. Rahalkar & Associates, Chartered Accountants, which provided an unmodified opinion on the audited annual financial results for the year March 31, 2026.
Financial Performance Highlights
The Statement of Audited Financial Results for the half year and year ended March 31, 2026, shows key operational figures. Total Revenue for the 6 months ended March 31, 2026, was ₹ 2,915.15 Lakhs, comprising Revenue from Operations of ₹ 2,873.66 Lakhs and Other Income of ₹ 41.49 Lakhs.The company's total expenses for the same period amounted to ₹ 2,718.66 Lakhs. This resulted in a Profit before exceptional and extraordinary items and tax of ₹ 196.49 Lakhs for the six months ended March 31, 2026. The corresponding figure for the previous year period (31/03/2025) was ₹ 2,359.96 Lakhs in Total Revenue and ₹ 2,961.80 Lakhs in Total Expenses.
The comparative data for the financial years are presented below:
| Particulars | 6 months ended (31/03/2026) (Audited) | Previous 6 months ended (30/09/2025) (Unaudited) | Corresponding 6 months ended (31/03/2025) (Audited) | Year to Date figure (31/03/2026) (Audited) | Previous year ended (31/03/2025) (Audited) |
|---|---|---|---|---|---|
| Revenue from Operations | 2,873.66 | 1,704.37 | 2,343.72 | 4,578.03 | 3,790.53 |
| Other Income | 41.49 | 21.10 | 16.23 | 62.60 | 26.92 |
| Total Revenue | 2,915.15 | 1,725.48 | 2,359.96 | 4,640.63 | 3,817.45 |
| Cost of Materials Consumed | 1,344.85 | 1,194.76 | 966.41 | 2,539.61 | 1,851.09 |
| Changes in inventories... | 275.68 | (126.43) | 276.24 | 149.26 | (80.40) |
| Employee benefits expense | 264.09 | 269.38 | 287.44 | 533.47 | 571.84 |
| Finance costs | 61.76 | 72.58 | 75.07 | 134.34 | 132.71 |
| Depreciation and amortization expense | 90.21 | 94.65 | 95.37 | 184.86 | 184.76 |
| Manufacturing, Operation, Admin and Other Expenses | 682.07 | 613.01 | 655.09 | 1,295.08 | 1,065.37 |
| Total expenses | 2,718.66 | 2,117.95 | 2,961.80 | 4,836.61 | 4,749.73 |
| Profit (Loss) for the period | 221.48 | (385.25) | (596.10) | (163.77) | (926.53) |
Balance Sheet Details
The Balance Sheet as of March 31, 2026, showed Shareholders' Fund totaling ₹ 1,278.28 Lakhs for Share Capital and a Reserves and Surplus of (₹ 1,719.65) Lakhs. Total current liabilities stood at ₹ 3,876.65 Lakhs.Key liabilities include:
- Long-term borrowings: ₹ 1,818.92 Lakhs (compared to ₹ 2,282.34 Lakhs in 2025).
- Total current liabilities: ₹ 3,876.65 Lakhs (compared to ₹ 4,273.31 Lakhs in 2025).
On the asset side, the company’s total assets remained at ₹ 3,876.65 Lakhs, matching the previous year. Inventories were valued at ₹ 793.93 Lakhs, and Trade Receivables were at ₹ 811.24 Lakhs.
Balance Sheet Comparison (In Rupees in Lakhs):
| Particulars | As at 31st March, 2026 | As at 31st March, 2025 |
|---|---|---|
| Equity and Liabilities | ||
| Share Capital | 1,278.28 | 1,278.28 |
| Reserves and Surplus | (1,719.65) | (1,555.89) |
| Long-term borrowings | 1,818.92 | 2,282.34 |
| Long-term provisions | 49.60 | 46.77 |
| Short-term borrowings | 1,357.92 | 1,320.87 |
| Trade Payables | 0.41 | 0.54 |
| Other Current Liabilities | 138.49 | 18.53 |
| Short-term provisions | 121.67 | 132.49 |
| Total Liabilities | 3,876.65 | 4,273.31 |
| Assets | ||
| Property, Plant & Equipments | 2,105.48 | 2,243.14 |
| Intangible assets | 0.98 | - |
| Capital work-in-progress | 19.36 | 7.85 |
| Long-term Loans and Advances | 2.09 | 2.11 |
| Other Non-current Assets | 26.83 | 25.59 |
| Inventories | 793.93 | 971.87 |
| Trade Receivables | 811.24 | 826.37 |
| Cash and Cash Equivalent | 68.91 | 56.87 |
| Short-term Loans and Advances | 41.54 | 133.48 |
| Total Assets | 3,876.65 | 4,273.31 |
Cash Flow Analysis
The Cash Flow Statement for the year ended March 31, 2026, indicated a Net cash from operating activities of ₹ 636.21 Lakhs, improving significantly from the negative cash flow of (₹ 715.27) Lakhs reported in the previous year.Cash Flow Comparison (Rupees in Lakhs):
| Particulars | Year ended 31st March, 2026 | Year ended 31st March, 2025 |
|---|---|---|
| Net cash from operating activities | 636.21 | (715.27) |
| Net cash used in investing activities | (63.46) | (132.03) |
| Net cash used in financing activities | (560.70) | 852.64 |
| Net increase in cash and cash equivalents | 12.05 | 5.34 |
| Cash and cash equivalents at end of period | 68.91 | 56.87 |
Appointment of Internal Auditors
In a separate operational update, the Board of Directors approved the appointment of M/s. Yatin and Associates, Chartered Accountants (FRN: 112100W), as the Internal Auditors of the Company for the financial year 2026-27.M/s Yatin & Associates are described as Chartered Accountants firms headed by CA Yatin Patwardhan, who has been in practice since 1992. The firm comprises a team of 24 young and experienced professionals whose expertise includes Due diligence, internal audit of corporate and non-corporate entities, Concurrent audit of banks for depository services, and statutory audits.
VSCL Stock Price Movement
On Wednesday, Vadivarhe Speciality Chemicals Limited shares gained 4.79% to close at ₹22.95. The stock saw a notable trading day, finishing with a volume of 12,000 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: